Published in Cancer Weekly, July 16th, 2002
The new manufacturing wing adds about 80,000 square feet and capacity for five commercial-scale production suites to MDS Nordion's existing facilities. It will house development as well as full-scale commercial production infrastructure for radiopharmaceuticals - drugs that incorporate radioisotopes as an active ingredient.
With completion expected in late 2003, each of the new facility's suites will be dedicated to a unique project that MDS Nordion is working on with a partner. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.